Skip to main content
Clinical Trials/NCT02337348
NCT02337348
Terminated
Not Applicable

Optical Coherence Tomography (OCT) Guided Compared to Conventional Angiography Guided Coronary Intervention in Stentfailure

Oslo University Hospital1 site in 1 country163 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Oslo University Hospital
Enrollment
163
Locations
1
Primary Endpoint
Target lesion revascularisation
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

Coronary artery intervention with stents is a routine procedure with several clinical indications. A stentfailure, ie stentrestenosis and/or stentthrombosis will occur in some patients. Several different mechanisms have been suggested. Stentfailure may be caused by mechanical properties of the stent. This may be secondary to suboptimal stentimplantation, ie over/undersizing or acquired ie malapposition or stentfracture. These stentproperties may be difficult to identify with conventional coronary angiography due to low image resolution. The hypothesis of the study is that high resolution imaging with optical coherence tomography (oct) will improve diagnosis and enable a more specific or tailored treatment with a subsequent reduction in later stentfailure.

Detailed Description

The hypothesis of the PROCTOR study is that high resolution imaging with optical coherence tomography (oct) will improve diagnosis and enable a more specific or tailored treatment in stent failure. However, the prevalence of stentfailure (ie stent malapposition, stentfracture, stentedgedissections etc) not causing clinical endpoints is not known. In a subset of patients (n=100) with previously implanted stents performing a new coronary angiography based on clinical indication, functional or patent stents (decided by Heart team) will be characterized with OCT and the patients followed for 5 years. The purpose of this substudy, OCT IPS (OCT In Patent Stents), is to estimate the prevalence of stentpathology in patent or functional stents and compare findings with the active arm of PROCTOR.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
January 31, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Eigil Fossum

MD, PhD

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Clinical indication for coronary angiography and intervention due to stentfailure, both stentrestenosis and stentthrombosis in stable patients or unstable patients with acute coronary syndrome.

Exclusion Criteria

  • Patient not able to give informed consent.
  • Unwillingness.
  • Life expectancy \< 5 years.
  • Reduced kidney function with GRF\<
  • Coronary artery diameter \< 2.5mm.
  • Pregnancy.
  • Patients without 11-digit Norwegian personal number.

Outcomes

Primary Outcomes

Target lesion revascularisation

Time Frame: 5 years

Secondary Outcomes

  • non-fatal myocardial infarction(5 years)
  • Cardiovascular mortality(5 years)

Study Sites (1)

Loading locations...

Similar Trials